26
16
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1219 |
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate
ANP (1-28), human, porcineANP(1-28) |
||
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate 是颗粒鸟苷酸环化酶的刺激剂,已被发现通过增加环鸟苷单磷酸的合成来保护分离的心肌细胞免受复氧诱导的高收缩。Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate 也有助于在反复运动期间刺激脂解,并在运动期间控制脂解。 | |||
T39244 |
Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled
|
||
Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled, is one of three mammalian natriuretic peptides (NPs) that exerts endocrine effects on fluid homeostasis and blood pressure. Atrial Natriuretic Peptide holds promise for cardiovascular diseases research. | |||
TP1221 |
Atrial Natriuretic Peptide (ANP) (1-28), rat
Atrial natriuretic factor (1-28) (rat) |
||
Atrial Natriuretic Peptide (1-28), rat is the major circulating form of ANP in rats. | |||
TP1220L |
ANP(1-28) Acetate (human, porcine)
醋酸卡培立肽,Carperitide acetate (89213-87-6 Free base),Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate |
Endothelin Receptor | GPCR/G Protein |
Carperitide acetate (Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate) 是一种由 28 个氨基酸组成的激素,由心脏产生并分泌,以响应心脏损伤和机械拉伸。Carperitide acetate 抑制内皮素-1 (endothelin-1) 分泌。 | |||
T41065 |
Atrial natriuretic factor (1-28) (human, porcine)
Atrial natriuretic factor (1-28) (human, porcine),Atrial natriuretic peptide (1-28) |
||
Atrial natriuretic factor (1-28) from both human and porcine sources is a powerful suppressor of pro-opiomelanocortin (POMC) mRNA, while it only has a modest inhibition effect on βEP-LI release. | |||
TP1218 |
Atrial natriuretic factor (1-28) (rat) TFA
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA |
||
Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1. | |||
TP1220 |
Carperitide
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine |
||
Carperitide, a 28-amino acid hormone known as Atrial Natriuretic Peptide (ANP) (1-28), is naturally synthesized and released by the human heart in reaction to cardiac injury and mechanical stretch. This compound effectively suppresses endothelin-1 secretion in a dose-dependent manner. | |||
T80438 |
Atrial natriuretic peptide (3-28) (human)
ANP (3-28) (human) |
Endothelin Receptor | GPCR/G Protein |
Atrial natriuretic peptide (3-28) (human) 是由心房心肌细胞合成并分泌的肽类激素,主要在调节血压、体液平衡及电解质稳态方面发挥作用。 | |||
T82932 |
Auriculin B
Atrial natriuretic peptide(126-150)(rat),ANP (126-150) (Rat) |
||
Auriculin B (ANP (126-150) (Rat)) 是源自大鼠的心房钠尿肽,具备显著的血管舒张与利尿作用。 | |||
T4200 |
Sacubitril hemicalcium salt
AHU-377 (hemicalcium salt),LCZ696中间体,AHU377 calcium salt |
Neprilysin | Metabolism |
Sacubitril hemicalcium salt (AHU377 calcium salt) 是一种有效的 NEP 抑制剂,IC50=5 nM。它是研究心力衰竭药物 LCZ696 的组分之一。 | |||
T30701 |
Candoxatrilat
UK69578,UK 69578,U 73967,U-73967,U73967,UK-69578 |
Others | Others |
Candoxatrilat (U 73967, UK69578) is an active neutral endopeptidase inhibitor that reduces atrial natriuretic peptide degradation. | |||
TP1872 |
Vasonatrin Peptide (VNP)
Vasonatrin Peptide VNP |
||
Vasonatrin peptide (VNP) is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) with potent venodilating and natriuretic activity. | |||
T81891 |
M65
|
||
M65为PAC1受体特异性拮抗剂,可抑制ANP释放。 | |||
T70471 |
Cgs 26303
|
Others | Others |
Cgs 26303 is a potent non-peptidic inhibitor of neutral endopeptidase capable of protecting atrial natriuretic peptide from enzymatic degradation. | |||
T76386 |
ANP (1-30), frog
|
||
ANP (1-30), frog 是蛙源心房肽的多肽片段。具有利钠、利尿和血管松弛作用。 | |||
T71987 |
5-hydroxy Isatin
|
Others | Others |
5-hydroxy Isatin is an inhibitor of monoamine oxidase A and also inhibits atrial natriuretic peptide-induced activation of particulate guanylyl cyclase in rat brain and heart membranes. | |||
T38641 |
AP 811
|
||
AP 811, a selective antagonist of the atrial natriuretic peptide clearance receptor (APN-CR, NPR3) with a K i value of 0.48 nM, exhibits remarkable selectivity for NPR3 over NPR1 by more than 20,000-fold. Moreover, AP 811 effectively eliminates ANP-induced pump stimulation. | |||
TP1630 |
A-71915 TFA (132956-87-7 free base)
A-71915 TFA |
||
A-71915 (TFA) is a selective inhibitor of ANP receptor (atrial natriuretic peptide-receptor), induces apoptosis and decreases insulin secretion in RINm5F pancreatic β-cells. | |||
T82847 |
BNP (1-21), Pro (Human)
|
||
BNP (1-21), Pro (Human) 是一种由21个氨基酸组成的心脏激素多肽。作为B型利钠肽(BNP)的一部分,与心房利钠肽高度同源,共同构成了心脏的双利钠肽系统。BNP 主要参与心脏发生的调节,并涉及向子宫外环境过渡的生理进程。 | |||
T76037 |
A-71915 TFA
|
||
A-71915 (TFA) 为一种选择性心房利钠肽受体 (ANP receptor) 抑制剂,其作用能够诱导 RINm5F 胰腺 β 细胞凋亡,并减少胰岛素释放。 | |||
T61095 |
SCH-42354
|
Others | Others |
SCH-42354 is a potent, orally active inhibitor of neutral endopeptidase (NEP), serving as the active form of the prodrug SCH-42495. By inhibiting NEP hydrolysis, SCH-42354 enhances the activity of atrial natriuretic peptide (ANP) and prevents the hydrolysis of leu-enkephalin and ANF with IC50 values of 8.3 nM and 10.0 nM, respectively. Furthermore, SCH-42354 exhibits antihypertensive activity [1] [2]. | |||
T78007 |
Vasonatrin Peptide (VNP) TFA
|
||
Vasonatrin Peptide (VNP) TFA 是一种由心钠素 (ANP) 和C型利钠肽 (CNP) 嵌合而成的肽类化合物。它整合了CNP的静脉扩张功能、ANP的利尿效果,并展现出与ANP或CNP无关的特有动脉扩张特性。Vasonatrin Peptide TFA 透过cGMP-PKG信号途径发挥其对内质网应激介导的糖尿病心脏缺血再灌注损害的保护作用。 | |||
TP2221 |
ANP (1-11), rat
|
Others | Others |
Atrial Natriuretic Peptide (ANP) has the sequence of H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, is a 28 amino acid peptide. ANP is a powerful vasodilator, and a protein (polypeptide) hormone secreted by heart muscle cells. It is involved in the hom | |||
T82993 |
AP 811 acetate
|
||
AP 811 acetate是一款选择性的ANP-CR(即NPR3)拮抗剂,其Ki值为0.48 nM。该化合物对NPR3的选择性是对NPR1的两万倍。此外,AP 811 acetate能够消除ANP诱导的泵激活现象。 | |||
T82941 |
Atriopeptin III (rat)
ANP 127-150 (rat) |
||
Atriopeptin III (ANP 127-150) (rat)是包含24个氨基酸的心房肽,作用为有效的血管舒张剂及利尿剂。在输尿管梗阻大鼠模型中,Atriopeptin III (rat)能够改善肾功能并降低血压,同时适用于慢性肾功能衰竭研究。 | |||
T83766 |
Moexiprilat
RS 10029 |
Others | Others |
Moexiprilat是一种血管紧张素转换酶(ACE; IC50 = 2.1 nM)的抑制剂,也是前药moexipril的一种活性代谢产物。通过侧链酯水解作用,在体内从moexipril转化而来。Moexiprilat (10 nM)能防止初生大鼠心脏成纤维细胞在雌激素或血管紧张素II刺激下的增殖。在以每天50 mg/kg剂量给药的去卵巢小鼠中,降低平均动脉血压,并增加心房钠尿肽水平,这是高血压的一个标志。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03250 |
NPR3 Protein, Rat, Recombinant (His & SUMO)
Npr3,Atrial natriuretic peptide r... |
Rat | E. coli |
Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity. NPR3 Protein, Rat, Recombinant (His & SUMO) is expressed in E. coli expression system wi... | |||
TMPH-00985 |
NPR3 Protein, Human, Recombinant (His)
Atrial natriuretic peptide recept... |
Human | E. coli |
Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity. NPR3 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-... | |||
TMPH-00982 |
NPR1 Protein, Human, Recombinant (E. coli, His)
Guanylate cyclase A,Atrial natriuretic |
Human | E. coli |
NPR1 Protein, Human, Recombinant (E. coli, His) is expressed in E. coli. | |||
TMPH-00983 |
NPR1 Protein, Human, Recombinant (His)
Guanylate cyclase A,Atrial natriuretic |
Human | P. pastoris (Yeast) |
NPR1 Protein, Human, Recombinant (His) is expressed in Yeast. | |||
TMPH-00984 |
NPR2 Protein, Human, Recombinant (His)
Atrial natriuretic peptide recept... |
Human | E. coli |
NPR2 Protein, Human, Recombinant (His) is expressed in E. coli. | |||
TMPH-00986 |
CORIN Protein, Human, Recombinant (His)
TMPRSS10,Pro-ANP-converting enzyme,Heart-specific serine pro... |
Human | E. coli |
CORIN Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 16.0 kDa and the accession number is Q9Y5Q5. | |||
TMPJ-00878 |
NPR3 Protein, Human, Recombinant (hFc)
ANPRC,ANPR-C,C5orf23,NPR-C,NPRC,NPR3,ANP-C |
Human | HEK293 Cells |
Atrial Natriuretic Peptide Receptor-3 (NPR3), also known as NPRC or ANPR-C, is one of the three natriuretic peptide receptors, is a type I transmembrane glycoprotein. The natriuretic system is key to the maintenance of vascular tone and cardiovascular homeostasis. Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for N... | |||
TMPJ-00874 |
NT-proBNP Protein, Human, Recombinant (His & Flag)
γ-brain natriuretic peptide,Gamma-brain |
Human | E. coli |
Brain-type Natriuretic Peptide (BNP) is a nonglycosylated peptide that is produced predominantly by ventricular myocytes and belongs to the natriuretic peptide family. Proteolytic cleavage of the 12 kDa BNP precursor gives rise to N-terminal Pro BNP (NT-proBNP) and mature BNP. N-terminal proB-type natriuretic peptide (NT-proBNP), a useful marker of heart failure (HF), is considered to be secreted mainly from the ventricle, increased serum NT-proBNP levels are also encountered in conditions such ... | |||
TMPY-04327 |
VEGFB Protein, Human, Recombinant (hFc)
VRF,血管内皮生长因子,vascular endothelial growth factor B,VEGFL |
Human | HEK293 Cells |
Vascular endothelial growth factor-B (VEGF-B) is closely related to VEGF-A, an effector of blood vessel growth during development and disease and a strong candidate for angiogenic therapies. In detail, VEGFB can positively prevent the Ang II-induced rising in the size of cardiomyocyte as well as reduce Ang II-induced mRNA and protein levels of β-MHC (β-myosin heavy chain), BNP (brain natriuretic peptide), and ANP (atrial natriuretic peptide). Moreover, VEGFB can regulate the decline of the Ang I... | |||
TMPY-02081 |
PDE2A Protein, Human, Recombinant (aa 215-900, His)
phosphodiesterase 2A, cGMP-stimulated,cGSPDE,PED2A4,PDE2A1,C... |
Human | Baculovirus Insect Cells |
cGMP-dependent 3',5'-cyclic phosphodiesterase, also known as cyclic GMP-stimulated phosphodiesterase and PDE2A, is a peripheral membrane protein that belongs to the cyclic nucleotide phosphodiesterase family and PDE2 subfamily. Phosphodiesterases (PDEs) comprise a family of enzymes that regulate the levels of cyclic nucleotides, key second messengers that mediate a diverse array of functions. Phosphodiesterases (PDEs) modulate signaling by cyclic nucleotides in diverse processes such as cardiac ... | |||
TMPK-01491 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HBV,Hepatitis B virus |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01501 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
MHC,Hepatitis B virus,HBV |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01505 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated
E7,MHC,HPV16 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01492 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi)
Hepatitis B virus,HBV,MHC |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01504 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi)
MHC,HPV16,E7 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01506 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi)
HPV16,E7,MHC |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. |